TP53 and lung cancer: This polymorphism generates variant proteins with an arginine (CGC) or proline (CCC) that modifies p53 protein ability to induce apoptosis, influences the action of mutant p53, reduces DNA repair efficacy and thus may be increased the risk of lung cancer.